3 completed, 2 terminated, 1 active not recruiting. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Terminated 2, Active not recruiting 1 |
Follow ALA: new trials by email Literature Review of ALA trials Research Report on ALA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy ALA, PDT - Basal Cell Carcinoma | Phase 2 | Active not recruiting | Case Comprehensive Cancer Center | 18 | 2021-12-13 | 2026-06-01 |
| Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face ALA, Topical Solution Vehicle, IBL 10 mW - Actinic Keratosis | Phase 2 | Completed | DUSA Pharmaceuticals, Inc. | 137 | 2016-03-01 | 2018-01-18 |
| Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy Aminolevulinic Acid, Topical Solution Vehicle, BLU-U - Actinic Keratosis | Phase 2 | Completed | DUSA Pharmaceuticals, Inc. | 166 | 2014-09-01 | 2018-08-24 |
| Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme aminolevulinic acid, therapeutic conventional surgery - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Terminated | Michael Vogelbaum, MD, PhD | 8 | 2012-05-01 | 2018-07-31 |
| A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors Aminolevulinic Acid - Malignant Glioma, Glioma | Phase 2 | Terminated | MultiCare Health System Research Institute | 16 | 2011-05-01 | 2016-03-17 |
| Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery Aminolevulinic Acid - Glioblastoma | Phase 2 | Completed | Matthew R Quigley | 72 | 2009-09-01 | 2019-04-12 |
Brain Neoplasms (3) · Glioblastoma (3) · Glioma (2) · Keratosis, Actinic (2) · Astrocytoma (1) · Carcinoma, Basal Cell (1) · Gliosarcoma (1)
DUSA Pharmaceuticals, Inc. (2) · Case Comprehensive Cancer Center (1) · Matthew R Quigley (1) · Michael Vogelbaum, MD, PhD (1) · MultiCare Health System Research Institute (1)
United States (6)
Stuart Marcus, MD, PhD (2) · Edward V Maytin, MD, PhD (1) · Matthew R Quigley, MD (1) · Michael Vogelbaum, MD, PhD (1) · Richard Shine, PharmD, BCPS (1) · William Morris, MD (1)